+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liquid Biopsy Market Global Forecast by Cancer, Product, Sample, Circulating Biomarkers, Regions, Company Analysis

  • PDF Icon

    Report

  • January 2021
  • Region: Global
  • Renub Research
  • ID: 5237710

A liquid biopsy is an emerging tool for the diagnosis of cancer disease nowadays. The liquid biopsy involves collecting samples and analysing tumours in the blood to diagnose cancer disease in the human body. Liquid biopsy assists medical practitioners as a source of genomic and proteomic knowledge in cancer patients by early detection of circulating tumour cells, DNA and extracellular vesicles. Currently, liquid biopsy plays a critical role in accelerating and implementing accurate oncology in clinical settings by leading to an improved understanding of tumour heterogeneity and allowing for dynamic control of reactions to care and variations in genomics. According to the research analysis, Global Liquid Biopsy Market is expected to be US$ 3.1 Billion by 2026.

The major growth drivers of liquid biopsies are that while extracting the tissue sample from the human body is much pain-free, it substitutes the pain associated with the procedure. Besides, liquid biopsy is very accurate in detecting tumour cells in the blood of cancer patients. Due to the low sensitivity of liquid biopsy, it acts as the restraint factor in the market's growth.

The key players play an essential role in the liquid biopsy market's growth by launching innovative products. In June 2020, NeoGenomics Inc. launched three liquid biopsy tests for non-small cell lung cancer, solid tumour types, and specific breast cancer. The COVID-19 effect in the liquid biopsy market has been harsh because all patients are taking therapies to treat cancer; since they have a weak immune system, and they are less prone to fight with coronavirus diseases.

The report titled “Liquid Biopsy Market Global Forecast by Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer & Others), Product (Kits & Consumables, Instruments and Services), Sample (Plasma/Serum, Urine & Others), Circulating Biomarkers (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs) & Exosomes), Clinical Application (Monitoring, Theranostics, Prognosis & Screening), Regions (Europe, North America, Latin America, Asia-Pacific and Middle East/Africa), Companies (Roche Diagnostics, Thermo Fisher Scientific Inc., Biocept Inc., Bio-Rad Laboratories Inc., Genomic Health, Biocartis, Myriad Genetics Inc., Qiagen, NeoGenomics Laboratories)” provides a detailed analysis of Global Liquid Biopsy Industry.

By Cancer

1. Lung Cancer

2. Breast Cancer

3. Colorectal Cancer

4. Prostate Cancer

5. Others

By Product

1. Kits & Consumables

2. Instruments

3. Services

By Circulating Biomarkers

1. Circulating Tumor Cells (CTCs)

2. Circulating Tumor DNA (ctDNA)

3. Extracellular Vesciles

4. Others

By Sample

1. Plasma/Serum

2. Urine

3. Others

By Clinical Application

1. Monitoring

2. Prognosis

3. Theranostics

4. Screening

By Regions

1. North America

2. Europe

3. Asia-Pacific

4. Latin America

5. Middle East/Africa

All the 9 Companies Studied in the Report have been Studied from three Points


  • Company Overview
  • Recent Development
  • Financial Insight

By Companies

1. Thermo Fisher Scientific Inc.

2. Roche Diagnostics

3. Bio-Rad Laboratories Inc.
4. Biocept Inc.

5. Biocartis

6. Myriad Genetics, Inc.

7. Genomic Health

8. NeoGenomics Laboratories

9. Qiagen


Frequently Asked Questions about the Global Liquid Biopsy Market

What is the estimated value of the Global Liquid Biopsy Market?

The Global Liquid Biopsy Market was estimated to be valued at $1.1 Billion in 2020.

What is the growth rate of the Global Liquid Biopsy Market?

The growth rate of the Global Liquid Biopsy Market is 18.7%, with an estimated value of $3.1 Billion by 2026.

What is the forecasted size of the Global Liquid Biopsy Market?

The Global Liquid Biopsy Market is estimated to be worth $3.1 Billion by 2026.

Who are the key companies in the Global Liquid Biopsy Market?

Key companies in the Global Liquid Biopsy Market include Thermo Fisher Scientific Inc., Roche Diagnostics, Bio, Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics, Inc., Genomic Health and Qiagen.

Table of Contents

1. Introduction2. Executive Summary
3. Market Dynamics
3.1 Growth Drivers
3.2 Challenges
4. Global - Liquid Biopsy Market
5. Market Share - Global Liquid Biopsy
5.1 By Region
5.2 By Cancer
5.3 By Product
5.4 By Circulating Biomarkers
6. Region - Liquid Biopsy Market
6.1 North America
6.2 Europe
6.3 Asia-Pacific
6.4 Latin America
6.5 Middle East & Africa
7. Cancer - Liquid Biopsy Market
7.1 Lung Cancer
7.2 Breast Cancer
7.3 Colorectal Cancer
7.4 Prostate Cancer
7.5 Others
8. By Product - Liquid Biopsy Market
8.1 Kits & Consumables
8.2 Instruments
8.3 Services
9. Circulating Biomarkers - Liquid Biopsy Market
9.1 Circulating Tumor cell (CTCs)
9.2 Circulating Tumor DNA (ctDNA)
9.3 Extracellular Vesicles (EVs)
9.4 Other Biomarkers (cell free DNA,etc)
10. By Clinical Application - Liquid Biopsy Market
10.1 Monitoring
10.2 Prognosis
10.3 Theranostics
10.4 Screening
11. By Sample - Liquid Biopsy Market
11.1 Plasma / Serum
11.2 Urine
11.3 Others
12. Company Analysis
12.1 Thermo Fisher Scientific Inc
12.1.1 Overview
12.1.2 Product Portfolio
12.2 Roche Diagnostics
12.2.1 Overview
12.2.2 Product Portfolio
12.2.3 Financial Insight
12.3 Bio-Rad Laboratories Inc
12.3.1 Overview
12.3.2 Product Portfolio
12.3.3 Financial Insight
12.4 Biocept, Inc.
12.4.1 Overview
12.4.2 Product Portfolio
12.5 Biocartis
12.5.1 Overview
12.5.2 Product Portfolio
12.5.3 Financial Insight
12.6 Myriad Genetics, Inc
12.6.1 Overview
12.6.2 Product Portfolio
12.6.3 Financial Insight
12.7 Genomic Health
12.7.1 Product Portfolio
12.7.2 Financial Insight
12.8 NeoGenomics Laboratories
12.8.1 Overview
12.8.2 Product Portfolio
12.8.3 Financial Insight
12.9 Qiagen
12.9.1 Overview
12.9.2 Product Portfolio
12.9.3 Financial Insight
List of Figures:
Figure 4-1: Global - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 4-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 5-1: By Region - Liquid Biopsy Market Share (%), 2015 - 2020
Figure 5-2: By Region - Forecast for Liquid Biopsy Market Share (%), 2021 - 2026
Figure 5-3: By Cancer - Liquid Biopsy Market Share (%), 2015 - 2020
Figure 5-4: By Cancer - Forecast for Liquid Biopsy Market Share (%), 2021 - 2026
Figure 5-5: By Product - Liquid Biopsy Market Share (%), 2015 - 2020
Figure 5-6: By Product - Forecast for Liquid Biopsy Market Share (%), 2021 - 2026
Figure 5-7: By Circulating Biomarkers - Liquid Biopsy Market Share (%), 2015 - 2020
Figure 5-8: By Circulating Biomarkers - Forecast for Liquid Biopsy Market Share (%), 2021 - 2026
Figure 6-1: United States Cancers by rates of New Cancer Cases (Male & Female) - 2015
Figure 6-2: United States Cancers by rates of Cancer Deaths (Male & Female) - 2015
Figure 6-3: Number of cancer deaths in Mexico in 2018, by cancer type (in Thousands)
Figure 6-4: North America - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 6-5: North America - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 6-6: Europe - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 6-7: Europe - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 6-8: Asia-Pacific - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 6-9: Asia-Pacific - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 6-10: Latin America - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 6-11: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 6-12: Middle East & Africa - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 6-13: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 7-1: Lung Cancer - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 7-2: Lung Cancer - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 7-3: Breast Cancer - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 7-4: Breast Cancer - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 7-5: Colorectal Cancer - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 7-6: Colorectal Cancer - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 7-7: Prostate Cancer - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 7-8: Prostate Cancer - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 7-9: Others - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 7-10: Others - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 8-1: Kits & Consumables - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 8-2: Kits & Consumables - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 8-3: Instruments - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 8-4: Instruments - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 8-5: Services - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 8-6: Services - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 9-1: CTCs - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 9-2: CTCs - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 9-3: ctDNA - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 9-4: ctDNA - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 9-5: Extracellular Vesicles - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 9-6: Extracellular Vesicles - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 9-7: Other Biomarkers - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 9-8: Other Biomarkers - Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 10-1: Monitoring - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 10-2: Monitoring - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 10-3: Prognosis - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 10-4: Prognosis - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 10-5: Theranostics - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 10-6: Theranostics - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 10-7: Screening - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 10-8: Screening - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 11-1: Plasma/Serum - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 11-2: Plasma/Serum - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 11-3: Urine - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 11-4: Urine - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 11-5: Others - Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 11-6: Others - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 12-1: Roche Diagnostics - Diagnostics Sales (Million US$), 2015 - 2020
Figure 12-2: Roche Diagnostics - Forecast for Diagnostics Sales (Billion US$), 2021 - 2026
Figure 12-3: Bio-Rad Laboratories - Net Sales (Million US$), 2015 - 2020
Figure 12-4: Bio-Rad Laboratories - Forecast for Net Sales (Million US$), 2021 - 2026
Figure 12-5: Biocept - Revenue (Million US$), 2015 - 2020
Figure 12-6: Biocept - Forecast for Revenue (Million US$), 2021 - 2026
Figure 12-7: Biocartis - Net Sales (Million US$), 2015 - 2020
Figure 12-8: Biocartis - Forecast for Net Sales (Million US$), 2021 - 2027
Figure 12-9: Myriad Genetics - Molecular Diagnostics Revenue (Million US$), 2015 - 2020
Figure 12-10: Myriad Genetics - Forecast for Molecular Diagnostics Revenue (Million US$), 2021 - 2026
Figure 12-11: NeoGenomics Laboratories - Net Sales (Million US$), 2015 - 2020
Figure 12-12: NeoGenomics Laboratories - Forecast for Net Sales (Million US$), 2021 - 2027
Figure 12-13: Qiagen - Revenue (Million US$), 2015 - 2020
Figure 12-14: Qiagen - Forecast For Revenue (Million US$), 2021 - 2027
List of Tables:
Table 6-1: Estimated number of people living with cancer: by nation, at the end of 2010, 2015, 2020 and 2030
Table 6-2: Cancer Statistics Japan - 2017

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Bio-Rad Laboratories Inc.
  • Biocept Inc.
  • Biocartis
  • Myriad Genetics, Inc.
  • Genomic Health
  • NeoGenomics Laboratories
  • Qiagen

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...